ConductScience.org, home
A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis
API referenceFor AI assistants

Trial · NCT02852967

Participant flow25

How many started, completed or left each group, period by period.

1 to 20 of 25

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDBelumosudil 200 mg QD + Placebo23
Overall StudySTARTEDBelumosudil 200 mg BID (Twice Daily) + Placebo22
Overall StudySTARTEDBelumosudil 400 mg QD + Placebo21
Overall StudySTARTEDBelumosudil 600 mg/Day26
Overall StudySTARTEDPlacebo18
Overall StudyCompleted Period 1: Double-blindBelumosudil 200 mg QD + Placebo14
Overall StudyCompleted Period 1: Double-blindBelumosudil 200 mg BID (Twice Daily) + Placebo15
Overall StudyCompleted Period 1: Double-blindBelumosudil 400 mg QD + Placebo17
Overall StudyCompleted Period 1: Double-blindBelumosudil 600 mg/Day16
Overall StudyCompleted Period 1: Double-blindPlacebo10
Overall StudyCompleted Period 2: Open-labelBelumosudil 200 mg QD + Placebo11
Overall StudyCompleted Period 2: Open-labelBelumosudil 200 mg BID (Twice Daily) + Placebo8
Overall StudyCompleted Period 2: Open-labelBelumosudil 400 mg QD + Placebo13
Overall StudyCompleted Period 2: Open-labelBelumosudil 600 mg/Day11
Overall StudyCompleted Period 2: Open-labelPlacebo14
Overall StudyCOMPLETEDBelumosudil 200 mg QD + Placebo9
Overall StudyCOMPLETEDBelumosudil 200 mg BID (Twice Daily) + Placebo6
Overall StudyCOMPLETEDBelumosudil 400 mg QD + Placebo9
Overall StudyCOMPLETEDBelumosudil 600 mg/Day4
Overall StudyCOMPLETEDPlacebo2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02852967/flow

API referenceFor AI assistants